Lite Strategy, Inc. Share Price
Lite Strategy, Inc. (LITS) had Share Price of $5.34 per share as of 2012-05-11, per its 10-Q filed 2013-02-12.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:SharePrice · last filed 2013-02-12
- 2012-05-11: Share Price $5.34; Share Price as first filed $0.89.
- 2011-06-30: Share Price $1.02.
- 2011-05-18: Share Price $1.35.
| Period end | Share Price | Share Price as first filed |
|---|---|---|
| 2012-05-11 | $5.34 10-Q · filed 2013-02-12 | $0.89 10-Q · filed 2012-11-13 |
| 2011-06-30 | $1.02 10-K · filed 2012-09-18 | |
| 2011-05-18 | $1.35 10-K · filed 2012-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |